ClinicalTrials.Veeva

Menu

Clinical Trial to Evaluate the Effect of an Oral Probiotic on the Vaginal Flora

I

Instituto Palacios

Status

Completed

Conditions

Vaginal Flora

Treatments

Dietary Supplement: Probiotic containing Lactobacillus Crispatus

Study type

Interventional

Funder types

Other

Identifiers

NCT03923985
SEID-Probiot

Details and patient eligibility

About

Clinical trial to evaluate the effect of a probiotic containing Lactobacillus Crispatus on the vaginal flora

Enrollment

40 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy women between 18 and 45 years old
  • Women without current symptoms of vaginal infection
  • Negative bacteriological and clinical examination

Exclusion criteria

  • Women with vaginal infection
  • Women with undiagnosed vaginal bleeding
  • Patients with endometrial hyperplasia
  • Suspicion of neoplasia or active neoplasia
  • Women with intolerance, allergy or hypersensitivity to the components of the probiotic
  • Women with immunosuppressive disorders or with HIV
  • Women who are currently using probiotics by any route of administration
  • Women who are using some treatment for vaginal sepsis
  • Chronic decompensated noncommunicable diseases (diabetes mellitus, heart disease ...)
  • Pregnant women or those with precocious menopause

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Active Arm
Active Comparator group
Description:
1 tablet / day of probiotic containing 10 Mld L. crispatus during two months
Treatment:
Dietary Supplement: Probiotic containing Lactobacillus Crispatus
Control Arm
No Intervention group
Description:
No treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems